HERCESSI™ becomes one of two trastuzumab biosimilars on preferred formulary placement, expanding patient access to more affordable HER2-targeted oncology therapies RALEIGH, N.C., Jan. 5, 2026 ...

Bitcoin (BTC-USD) headed for a third straight month of losses on Wednesday, capping a year defined by record highs and a dramatic crash. On the last trading day of the year, the token hovered near $88 ...

Fintel reports that on December 22, 2025, Citigroup maintained coverage of Strategy Inc - Preferred Stock (NasdaqGS:STRF) with a Buy recommendation. Analyst Price Forecast Suggests 213.83% Upside As ...

Fintel reports that on December 22, 2025, Citigroup maintained coverage of Strategy Inc - Preferred Stock (NasdaqGS:STRF) with a Buy recommendation. As of December 21, 2025, the average one-year price ...

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. In this episode, Thomas Betts chats with ...

BitMine Immersion Technologies Inc (NYSE: BMNR) shares are trading higher Monday. The company announced that it now owns more than 3.2% of the total Ethereum supply, marking two-thirds progress toward ...

Fintel reports that on December 8, 2025, Bernstein maintained coverage of Strategy Inc - Preferred Stock (NasdaqGS:STRF) with a Outperform recommendation. Analyst Price Forecast Suggests 193.43% ...

Strategy’s (MSTR) senior perpetual preferred stock, STRF, is increasingly standing out as the company’s most successful credit instrument since its launch in March. Trading at $110, STRF has risen 36% ...

When your entire corporate game plan and the investor base you’ve cultivated revolves around the rising price of bitcoin, a 35% tumble in a month is cause for alarm. Last week bitcoin fell to $82,000, ...